1. Canada Stocks

  2. •

    Non-energy minerals

  3. •

    Precious metals
Black Mammoth Metals Corporation

Black Mammoth Metals Corporation

4.24
CAD
-0.37
(-8.03%)
-0.04EPS
198.92MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.16
-0.07
0.03
-0.01
-0.03
-0.01
- -
-0.01
0.02
-0.01
-0.01
-0.02
-0.02
-0.04
Free Cash Flow per Basic Share
-0.01
- -
- -
-0.02
-0.05
-0.02
-0.01
- -
-0.01
-0.02
0.01
-0.03
-0.01
-0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.23
-0.3
-0.27
-0.1
-0.01
-0.01
- -
-0.01
0.01
0.02
0.02
0.21
0.26
0.3
Tangible Book Value per Share
-0.23
-0.3
-0.27
-0.1
-0.01
-0.01
- -
-0.01
0.01
0.02
0.02
0.21
0.26
0.3
Basic Weighted Avg Shares
2
3
3
5
7
11
11
11
11
14
15
26
37
42
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
-1
-1
-1
- -
- -
- -
- -
- -
- -
- -
- -
3
1
2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
-1
-1
-1
- -
- -
- -
- -
- -
- -
- -
7
10
14
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
176,531
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-10.73
- -
- -
- -
-52.71
- -
176,529.26
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
-69.28
-40.08
-16.38
-7.08
-16.51

Capital Structure

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
40
46
46
Market Capitalization
222
212
199

Working Capital

CAD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1
2
3
Cash, Cash Equivalents & STI
1
2
3
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
1
Payables & Accruals
- -
- -
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
207.54%
394.35%
52.89%
Free Cash Flow
7,093.87%
-135.06%
-43.77%
Net Income, GAAP
-46.29%
-25.37%
3.55%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
-0.01
-0.01
-0.02
2025
- -
-0.01
- -
- -
-0.02
2026
-0.03
-0.01
- -
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Dustin Christopher Henderson
Full Time Employees
- -
Sector
Non-energy minerals
Industry
Precious metals
Address
Suite 1710, 1177 West Hastings Street Vancouver BC Canada V6E 2L3
IPO Date
Dec 14, 2005
Website
blackmammothmetals.com
Similar Companies
Newmont Corporation (NYSE:NEM)
Polus (MOEX:PLZL)
Critical Metals Corp. (NASDAQ:CRML)
Turk Altin Isletmeleri A.S. (BIST:TRALT)
Hecla Mining Company (NYSE:HL)
Coeur Mining, Inc. (NYSE:CDE)
Business
Biomimix, Inc. (BMMX) develops and commercializes biomimicry-based products and technologies that model nature's processes, systems, and elements to address medical needs, operating in the life science tools and services market spanning genomics, proteomics, cell biology, and analytical chemistry; through its subsidiary C'watre LLC, the company provides a skincare line formulated with molecularly stimulated ocean water containing 78 nanonutrients, including kanreki wash, kanreki tonic, kanreki cream, kanreki serum, haeru activating ageless serum, and c’tea Skincare From Within for professional spas, resorts, medical centers, and retail beauty outlets. Note that BiomimX Srl, an unrelated Italian entity and spin-off of Politecnico di Milano founded in recent years with headquarters in Milano, pioneers beating organs-on-chip platforms like the proprietary uBeat technology for dynamic 3D cell culture models including uHeart (beating human heart-on-chip), uKnee (healthy and osteoarthritic cartilage), uGut (gastrointestinal tract with epithelium and endothelium), and uScar (cardiac fibrosis), alongside services for drug discovery, safety-toxicology testing, efficacy prediction in disease models, advanced therapies, and microbiome interactions, but lacks direct affiliation with BMMX. The company maintains a public listing on OTC Markets with limited recent operational disclosures; no major funding rounds, acquisitions, partnerships, or strategic shifts within the last 1-2 years are publicly reported as of December 2025, though historical activities include skincare product commercialization via C'watre.